| Literature DB >> 32724327 |
Chen Wang1, Shuang Ling1, Jin-Wen Xu1.
Abstract
Stem cells (SCs) are special types of cells with the ability of self-renewal and multidirectional differentiation. As the organism ages, the ability to maintain homeostasis and regeneration deteriorates and the number and activity of stem cells decline. Theoretically, the restoration of stem cells might reverse aging. However, due to their own aging, donor-derived immune rejection, and difficulties in stem cell differentiation control, a series of problems need to be solved to realize the potential for clinical application of stem cells. Chinese herbal medicine is a nature drug library which is suitable for the long-term treatment of aging-related diseases. Modern pharmacological studies have revealed that many active ingredients of Chinese herbal medicines with the effect of promoting stem cells growth and differentiation mainly belong to "reinforcing herbs." In recent years, exploration of natural active ingredients from Chinese herbal medicines for delaying aging, improving the stem cell microenvironment, and promoting the proliferation and differentiation of endogenous stem cells has attracted substantial attention. This article will focus on active ingredients from Chinese herbs-mediated differentiation of stem cells into particular cell type, like neural cells, endothelial cells, cardiomyocytes, and osteoblasts. We will also discuss the effects of these small molecules on Wnt, Sonic Hedgehog, Notch, eNOS-cGMP, and MAP kinase signal transduction pathways, as well as reveal the role of estrogen receptor α and PPAR γ on selectively promoting or inhibiting stem cells differentiation. This review will provide new insights into the health aging strategies of active ingredients in Chinese herbal medicine in regenerative medicine.Entities:
Year: 2020 PMID: 32724327 PMCID: PMC7366228 DOI: 10.1155/2020/7307026
Source DB: PubMed Journal: Evid Based Complement Alternat Med ISSN: 1741-427X Impact factor: 2.629
Small molecule compounds from Chinese medical herbs inducing stem cell differentiation.
| Active ingredients | Differentiated cells | Stem cells or model | Pathways | Effects | References |
|---|---|---|---|---|---|
| Astragaloside IV | Endothelial cell-like cells | Rat mesenchymal stem cells | N/A | 1. Differentiated into endothelial cell-like cells and promoted tube formation in vitro | [ |
| Neuronal cells | Rat neural stem cells | Sonic hedgehog | 1. Differentiation into dopamine neurons | [ | |
|
| |||||
| Astraisoflavan | Neuronal cells | Rat neural stem cells | Sonic hedgehog | 1. Differentiation into dopamine neurons | [ |
|
| |||||
| Aucubin | Neuronal cells | Rat neural stem cells and neural precursor cells | N/A | 1. Promoted lengthening and thickness of axons and remyelination at 3 weeks after sciatic nerve injury | [ |
|
| |||||
| Baicalin | Cardiomyocytes | Murine embryonic stem cells | N/A | 1. Increased the proportion of | [ |
| Neuronal cells | Neural stem cells derived from the cortex of embryonic E15-16 SD rats | N/A | 1. Increased the percentages of mature neuronal marker MAP-2-positive staining cells and decreased glial marker GFAP staining cells | [ | |
| Osteoblasts | N/A | Wnt/ | 1. Increased significantly the osteoblastic mineralization levels of mRNAs encoding the bone differentiation markers OCN, OPN, and COL-1 | [ | |
|
| |||||
| Bavachalcone | Endothelial cells | Rat bone marrow mesenchymal stem cells and rat hindlimb ischemia model | ROR | 1. Promoted rat bone marrow-derived cells to differentiate into EPC significantly | [ |
|
| |||||
| Berberine | Osteoblasts | Bone marrow-derived mesenchymal stem cells | Wnt/ | Promoted osteogenic differentiation and osteogenic genes Runx2, OPN, and OCN expression | [ |
|
| |||||
| Catalpol | Osteoblasts | Bone marrow mesenchymal stem cells | Wnt/ | 1. Enhances the osteogenic differentiation | [ |
|
| |||||
| Curcumin | Cardiomyocytes | Human embryonic stem cells | NO-cGMP signaling | 1. Promoted differentiation into cardiomyocytes | [ |
|
| |||||
| Ginkgolide B | Endothelial progenitor cells | Human bone marrow | Akt/eNOS and p38 MAPK signaling | 1. Promoted proliferation and endothelial gene expression, significantly enhanced VEGF-induced migration response, and improved the vascular network composition of EPCs | [ |
| Neuronal cells | Neural stem cells derived from mouse subventricular zone (SVZ) | Wnt/ | 1. Promoted neuronal differentiation | [ | |
| Osteoblasts | Rat bone mesenchymal stem cells and MC3T3-E1 cells | Wnt signaling | 1. Promotes osteoblast differentiation | [ | |
|
| |||||
| Ginsenoside Rb1/RE | Cardiomyocytes | Human embryonic stem cell | N/A | 1. Enhanced differentiation into cardiomyocytes | [ |
|
| |||||
| Ginsenoside Rg1 | Neuronal cells | Mouse embryonic stem cells and human adipose-derived stem cells | Wnt/ | 1. Promoted cell proliferation and neural phenotype differentiation | [ |
|
| |||||
| Ginsenoside RH2 (S) | Osteoblasts | MC3T3-E1 cells | PKD/AMPK signaling | 1. Stimulated osteoblastic differentiation and mineralization | [ |
|
| |||||
| icariin | Cardiomyocytes | Mouse embryonic stem cells | p38 MAPK pathway in early differentiation and NO-cGMP signaling | 1. Facilitated the directional differentiation of ES cells into cardiomyocytes | [ |
| Osteoblasts | Rat bone mesenchymal stem cells | ER | 1. Significantly enhanced osteogenic differentiation and increased ALP activity and Lef1, TCF7 DLX5, OPN, OCN, COLI, ER | [ | |
|
| |||||
| Kaempferol | Osteoblasts | Rat bone mesenchymal stem cells | Interaction between TAZ and RUNX2 | Promoted physical interaction between TAZ and RUNX2 to increase osteoblast differentiation of mesenchymal cells | [ |
|
| |||||
| Ligustilide | Osteoblasts | MC3T3-E1 cells and rat bone mesenchymal stem cells | GPR30/EGFR pathway | 1. Promoted osteoblast differentiation | [ |
|
| |||||
| Myricetin | Osteoblasts | Human bone marrow stem cells and human periodontal ligament stem cells | Wnt/ | 1. Enhanced osteogenic differentiation | [ |
|
| |||||
| Polydatin | Osteoblasts | Human bone marrow stromal cells and OVX mouse model | BMP-2-Wnt/ | 1. Significantly improved the proliferation and calcium deposition of hBMSCs and markedly stimulated the expression of the mRNAs RUNX2, OPN, DLX5, | [ |
|
| |||||
| Puerarin | Osteoblasts | Rat bone marrow stromal cells | Estrogen receptor-dependent manner | 1. Enhanced osteoblast differentiation | [ |
| Quercetin | Osteoblasts | Human adipose tissue-derived stromal cells, mouse adipose stem cells, rat mesenchymal stem cells, and rat bone marrow-derived mesenchymal stem cells | p38 MAPK, ERK1/2 and JNK MAPK signaling | 1. Promoted the osteogenic differentiation | [ |
|
| |||||
| Resveratrol | Neuronal-like cells | Human bone marrow mesenchymal stem cells and human cord blood-derived mesenchymal stem cells | Sonic hedgehog signaling, PKA-GSK3 | 1. Differentiated into neuronal-like cell types | [ |
| Osteoblasts | Mouse embryonic stem cells, rat adipose-derived mesenchymal stem cells | AMPK/Ulk1 pathway, and Sirt-1/Runx2 deacetylation | 1. Enhancing osteogenic differentiation and mineralization | [ | |
|
| |||||
| Salidroside | Neuronal cells | Rat bone marrow mesenchymal stem cells, mouse mesenchymal stem cells | Notch and BMP signaling pathways | 1. Inhibited the proliferation, increased expression level of NSE, BDNF, MAP2, | [ |
|
| |||||
| Salvianolic acid a/B | NF-M (+) neurons and NG2 (+) oligodendrocyte precursors | Neural stem cells derived from the cerebral cortex of embryonic mice, bone marrow-derived neural stem cells, and induced pluripotent stem cells | PI3K/AKT/GSK3 | 1. Promoted the neurite outgrowth of neural stem cells and their differentiation into neurons | [ |
| Osteoblasts | Human mesenchymal stem cells and rat bone marrow stromal stem cells | ERK signaling and NO-cGMP signaling | 1. Significantly promoted mineralization | [ | |
| Hepatocytes | Human embryonic stem cells | Through upregulation of WNT pathway and inhibition of Notch pathway | 1. Promoted hepatocyte differentiation and increased expression of albumin, tyrosine aminotransferase (TAT), CYP3A4, CYP2C19, UGT1A6, UGT1A8, and UGT2B7 | [ | |
| Alveolar epithelial cells type I | Rat bone marrow mesenchymal stem cells | WNT pathway | 1. By day 14, the majority of bone marrow mesenchymal stem cells were morphologically differentiated into alveolar epithelial cells | [ | |
|
| |||||
| Silibinin | Osteoblasts | Human bone marrow stem cells | Activating BMP and RUNX2 pathways | 1. Promoted ALP activity and mineralization in hBMSCs | [ |
|
| |||||
| Tanshinone IIA | Neuronal-like cells | Rat bone marrow mesenchymal stem cells | N/A | Significantly upregulated the expression levels of Nestin, NeuN, and NF200 in the transplanted cells in the BMSCs + tanshinone IIA treatment rats compared among the groups | [ |
| Osteoblasts | Mouse bone marrow mesenchymal stem cells and human periodontal ligament stem cells | ERK1/2-dependent Runx2 induction and BMP-Wnt signaling | 1. Enhanced ALP activity on day 7 and calcium content on day 24 in the process of TSA-induced osteogenesis of mouse bone marrow mesenchymal stem cells | [ | |
|
| |||||
| 2,3,5,4'- Tetrahydroxy- stilbene-2-O- | Osteoblasts | Rat mesenchymal stem cells | N/A | Promoted osteogenic differentiation and increased ALP activity and OCN expression | [ |
Figure 1Schematic diagram of signaling in neural cell differentiation induced by active ingredients of traditional Chinese medicine. BDNF: brain-derived neurotrophic factor; Shh: sonic hedgehog.
Figure 2Schematic diagram of signaling in endothelial cell differentiation induced by active ingredients of traditional Chinese medicine. EPO: erythropoietin; VEGF: vascular endothelial growth factor; Shh: sonic hedgehog.
Figure 3Schematic diagram of signaling in cardiomyocyte differentiation induced by active ingredients of traditional Chinese medicine. VEGF: vascular endothelial growth factor; NRG-1β: neuregulin-1β; AVP: arginine vasopressin; Shh: sonic hedgehog.
Figure 4Schematic diagram of signaling in osteoblast differentiation induced by active ingredients of traditional Chinese medicine. BMP-2: bone morphogenetic protein-2.